Module XVIII -  New FDA Actions II

Wednesday May 26, 1999 - Question 2

Which of the following statements concerning fosphenytoin (Cerebyx) is correct?

A) Fosphenytoin is a parenteral anticonvulsant used for long-term control of seizures.

B) Fosphenytoin is a racemic mixture of d & l phenytoin.

C) Formaldehyde toxicity has been associated with fosphenytoin administration.

D) Serious adverse events with fosphenytoin have been attributed to the product labeling.

E) Fosphenytoin should always be converted to an equivalent amount of phenytoin.
.
 

Discussion